暂无标题

XIONG Wei; LI Xiaoxia; ZHANG Qixiang

您当前的位置：

首页 >

文章列表页 >

暂无标题

更新时间：2023-03-01

- 暂无标题
- China Pharmacy Vol. 30, Issue 20, (2019)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2019，
扫描看全文
XIONG Wei, LI Xiaoxia, ZHANG Qixiang. [J]. China Pharmacy 30(20).(2019)
DOI：

XIONG Wei, LI Xiaoxia, ZHANG Qixiang. [J]. China Pharmacy 30(20).(2019) DOI：

摘要

目的：为提高医院高警示药品管理工作水平提供参考。方法：基于美国医疗机构评审国际联合委员会（JCI）和美国医疗信息与管理系统学会（HIMSS）管理要求，建立我院高警示药品管理模式，包括高警示药品目录制订、标识与储存、医嘱开具、医嘱审核、调剂与使用、用药后监测等重点管理环节，并进行成效分析。结果：我院高警示药品管理措施实施后，药品存放合格率由实施前的29.28％提高到实施后的95.50％，涉及高警示药品的不合理医嘱率由实施前的3.43％下降到实施后的1.99％，实施前后比较差异均有统计学意义（P＜0.01）；调剂差错由每月35起减少至0，高警示药品相关不良事件从实施前每月18起减少至每月3起，用药安全性明显提高。结论：我院建立了基于JCI和HIMSS标准的高警示药品管理模式，有助于规范高警示药品的管理，降低其使用风险。

Abstract

OBJECTIVE： To provide reference for the management of high-alert medicine. METHODS： Based on the requirements of JCI and HIMSS standards， the mode of high-alert medicine management were established， including formulation of high-alert medicine list， identification and storage， prescribing medical order， reviewing medical order， dispensing and application， post-administration monitoring and other key management links. Then the effectiveness analysis was carried out. RESULTS： After implementing high-alert medicine management measures， the qualification rate of high-alert medicine storage increased from 29.28％ to 95.50％ and the incidence of irrational medical order involving high-alert medicine decreased from 3.43％ to 1.99％， with statistical significance （P＜0.01）. The errors of dispensing was reduced from 35 to 0 monthly， high-alert medicine-related adverse events reduced from 18 to 3 monthly， and the safety of high-alert medicine was greatly improved. CONCLUSIONS： Through the establishment of high-alert medicine management model based on JCI and HIMSS standards in our hospital， the management of high-alert medicine is standardized， the risk of drug use is reduced.

关键词

美国医疗机构评审国际联合委员会美国医疗信息与管理系统学会高警示药品药品管理

Keywords

JCIHIMSSHigh-alert medicineDrug management

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

我院门诊药房使用智能发药系统发现的问题与相关改进

JCI与我国医院评审标准中药事管理方面内容的比较及启示

Practice of Multidisciplinary Collaborative Prescription Review Mode in Key Monitored Drugs Management in Our Hospital

Status of Residual Drug Management in 50 Medical Institutions in China and Its Control Mode Construction and Appli cation Practice in Our H ospital

Multi-dimensional Focus on the Management and Clinical Use of Biosimilar Products

Related Author

WANG Yi

DENG Aiping

WANG Jun

LI Maochun

YE Lu

WANG Menglei

CHEN Hongdou

YANG Qingqing

Related Institution

No data

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

暂无标题

DOI：

摘要

Abstract

关键词

Keywords

references